Related Experiment Video
Updated: Jul 20, 2026

Identification of Protein Interacting Partners Using Tandem Affinity Purification
Published on: February 25, 2012
Identification and characterization of proteins interacting with Traf4, an enigmatic p53 target
Laura M Rozan1, Wafik S El-Deiry
1Department of Medicine (Hematology/Oncology), Institute for Translational Medicine and Therapeutics and Abramson Comprehensive Cancer Center, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA.
Abstract:
Tumor necrosis factor receptor associated factor 4 (Traf4) mRNA expression is upregulated in various breast tumors and tumor cell lines. We previously identified Traf4 as a p53 target gene, and showed overexpression of Traf4 inhibited colony formation. However, basal Traf4 expression in cell lines does not appear to be dependent entirely on p53. To address the putative function of Traf4, a yeast 2-hybrid screen and coimmunoprecipitation/mass spectrometry experiments were performed to identify Traf4-interacting proteins. A yeast 2-hybrid using full length Traf4 as bait yielded several candidate interacting proteins including beta-catenin, GRIM19, PSMC3, p62 and dynamin. Although all of these proteins are novel interactors for Traf4, PSMC3 and p62 have been previously demonstrated to interact with the related protein, Traf6. Traf4 appears to enhance beta-catenin related transcription as well as to provide some protection of beta-catenin protein levels from p53-mediated degradation although a direct interaction was not observed in mammalian cells. To obtain interacting proteins using a more physiologically relevant environment, we immunoprecipitated Flag-tagged Traf4 followed by mass spectrometry which identified other novel Traf4 interacting proteins including Eg5, PRMT5, and MYH-9.
Insights
Tumor necrosis factor receptor associated factor 4 (Traf4) is upregulated in breast tumors. Traf4 interacts with beta-catenin, potentially influencing transcription and protein stability, and its function is explored through protein interaction studies.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Tumor necrosis factor receptor associated factor 4 (Traf4) mRNA is upregulated in breast tumors.
- Traf4 was previously identified as a p53 target gene, with overexpression inhibiting colony formation.
- Basal Traf4 expression is not solely dependent on p53.
Purpose of the Study:
- To identify Traf4-interacting proteins and elucidate its function.
- To investigate Traf4's role in beta-catenin regulation.
- To explore Traf4's interactions in a physiological context.
Main Methods:
- Yeast two-hybrid screens with full-length Traf4 bait.
- Coimmunoprecipitation followed by mass spectrometry.
- Mammalian cell-based interaction studies.
Main Results:
- Yeast two-hybrid identified beta-catenin, GRIM19, PSMC3, p62, and dynamin as Traf4 interactors.
- Traf4 enhances beta-catenin-related transcription and protects beta-catenin from p53-mediated degradation.
- Mass spectrometry identified Eg5, PRMT5, and MYH-9 as novel Traf4 interactors in mammalian cells.
Conclusions:
- Traf4 interacts with multiple proteins, including beta-catenin, suggesting diverse functional roles.
- Traf4 influences beta-catenin stability and transcriptional activity.
- Novel Traf4-interacting proteins were identified, expanding the understanding of Traf4's molecular network.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

